NCT07387198
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07387198
Title Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab (NeoMatryx)
Acronym NeoMatryx
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Nationales Centrum für Tumorerkrankungen Heidelberg Baden-Wurttemberg 69120 Germany Details
Universitätsklinikum Mannheim Mannheim Baden-Wurttemberg 68161 Germany Details
Universitätsklinikum Tübingen Tübingen Baden-Wurttemberg 72076 Germany Details
Universitätsklinikum Regensburg Regensburg Bavaria 93053 Germany Details
Universitätsklinikum Würzburg Würzburg Bavaria 97080 Germany Details
Universitätsklinikum Hamburg-Eppendorf Hamburg Hamburg 20246 Germany Details
Universitätsklinikum Frankfurt Frankfurt am Main Hesse 60590 Germany Details
Klinikum Bielefeld Bielefeld North Rhine-Westphalia 33647 Germany Details
Universitätsklinikum Köln Cologne North Rhine-Westphalia 50937 Germany Details
Universitätsklinikum Essen Essen North Rhine-Westphalia 45147 Germany Details
Johannes Wesling Klinikum Minden Minden North Rhine-Westphalia 32429 Germany Details
Universitätsmedizin Mainz Mainz Rhineland-Palatinate 55131 Germany Details
Universitätsklinikum Leipzig Leipzig Saxony 04103 Germany Details
Helios Klinikum Erfurt Erfurt Thuringia 99089 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field